Jubilant Pharma completes stake sale in Sofie Biosciences
Merger with Trilantic Capital Partners leads to strategic disinvestment Jubilant Pharma (JPL), has finalised the sale of its…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Jubilant Pharma
Jubilant Pharma to sell its 25.8 per cent stake in Sofie Biosciences for $139.43 mn
Of this, $113.63 million is expected to be received upon completion of the merger while receipt of balance sum of $25.8 million is…
Jubilant Pharma arm to raise $400 million loan from StanChart Bank to repay debt
The majority of the amount will be used for repayment of the existing term loan and debt bonds
Aurobindo and Sun Pharma recall products in US market
While Aurobindo Pharma is recalling Cyanocobalamin injection, Sun Pharma is recalling a drug used to increase the production of…
Manufacturing capacity of Remdesivir ramped up to around 1.19 cr crore vials a month: Govt
With the accelerated approval of 38 additional manufacturing sites, the number of approved manufacturing sites of remdesivir in…
Sun Pharma, Dr Reddy’s, Aurobindo, Jubilant recall products in US
The Indian firms have initiated recall of these products for various reasons including failed impurities/degradation…
Jubilant Pharma and Aavis Pharma launch Hydroxychloroquine Sulfate tablets in US
The product will be distributed by Jubilant Cadista, a unit of Jubilant Pharma
Jubilant Life Sciences appoints Gurpartap Singh Sachdeva as CEO
Jubilant Life Sciences has appointed Gurpartap Singh Sachdeva has been appointed as the Chief Executive Officer, Jubilant Pharma,…